ラジオイムノアッセイ（RIA）- 世界市場の考察、競合情勢、市場予測（2030年）

世界のラジオイムノアッセイ（RIA）の市場規模は、2023年に5億2,398万米ドル、2030年までに6億6,031万米ドルに達し、2024年～2030年の予測期間にCAGRで3.36％の成長が見込まれます。ラジオイムノアッセイ（RIA）の需要は主に、がん、感染症などの有病率の増加、疫病やパンデミックの罹患率の上昇、健康に対する意識の高まりによって後押しされています。さらに、市場はこの分野で進行中の多数の研究活動、医療提供者や研究者、業界参入企業の協力、戦略的パートナーシップなどが、2024年～2030年の予測期間に市場の全体的な成長に寄与する見通しです。

ラジオイムノアッセイ（RIA）の市場力学

International Agency for Research on Cancerが実施した調査によると、2020年に世界で推定1,930万人の新規がん症例が報告されました。

世界保健機関（WHO）のデータによると、2020年に世界で乳がん226万件、肺がん221万件、大腸がん193万件、前立腺がん141万件、胃がん109万件が報告されています。

がんの増加により早期かつ効果的な診断が必要となり、これはラジオイムノアッセイ（RIA）を使用することで可能となります。ラジオイムノアッセイ（RIA）は、大腸がんや膵臓がんなどの早期発見に極めて重要であることが分かっています。

また、世界保健機関（WHO）（2022）によると、2020年に世界で約3,770万人がヒト免疫不全ウイルス（HIV）に感染しています。WHOの2023年のデータによると、2022年に全世界で約1,000万人が結核に罹患していました。この推計は、感染症の有病率が増加傾向にあり、その効果的な診断に向けたラジオイムノアッセイ（RIA）の需要が増加することを示しています。

しかし、放射性物質の使用や、先進の実験施設の必要性、その他の診断ツールや方法と組み合わせたラジオイムノアッセイ（RIA）の使用に関連する制約などの複数の制約が、ラジオイムノアッセイ（RIA）市場全体の成長を抑制する可能性があります。

ラジオイムノアッセイ（RIA）市場のセグメント分析

ラジオイムノアッセイ（RIA）市場の製品タイプでは、分析器が2023年に大きな収益シェアを獲得する見込みです。

これは、世界中での伝染病やパンデミックの罹患率の上昇と、肝炎などの感染症の高い罹患率によるものと考えられます。

WHO（2022）のデータによると、2020年に世界で約2億4,100万人がマラリアに罹患しました。

WHO（2021）のデータによると、世界中で毎日約100万人が性病に感染しています。また、同データによると、2020年にクラミジア約1億2,900万件、梅毒710万件、淋病8,200万件、トリコモナス約1億5,600万件が存在したと推定されています。

米国疾病対策予防センター（2021）によると、WHOの推定に基づき、2019年に全世界で約2億9,600万人がB型肝炎に罹患し、5,800万人がC型肝炎に罹患していました。

ラジオイムノアッセイ（RIA）分析器は、サンプル中の特定物質の濃度を同定および検出するために使用され、さまざまな検査を行うことができます。分析器は信頼性が向上し、直感的なインターフェースと使いやすい機能を備えています。

したがって、上記の要因から分析器カテゴリが大きな成長を記録すると予測され、それによって予測期間のラジオイムノアッセイ（RIA）市場全体の成長を促進します。

北米はラジオイムノアッセイ（RIA）市場全体を独占すると予測されます。

米国疾病予防管理センター（2022）によると、2019年に米国で13歳以上の約118万9,700人がHIVに感染していると推定されました。米国疾病対策予防センター（CDC）（2022）によると、2019年に約175万2,735人の新規がん症例が報告されました。

当レポートでは、世界のラジオイムノアッセイ（RIA）市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 ラジオイムノアッセイ（RIA）市場レポートのイントロダクション

第2章 ラジオイムノアッセイ（RIA）市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 ラジオイムノアッセイ（RIA）市場の主な要因の分析

• ラジオイムノアッセイ（RIA）市場の促進要因
• ラジオイムノアッセイ（RIA）市場の抑制要因と課題
• ラジオイムノアッセイ（RIA）市場の機会

第5章 ラジオイムノアッセイ（RIA）市場のポーターのファイブフォース分析

第6章 ラジオイムノアッセイ（RIA）市場のレイアウト

• 製品タイプ
  • 分析器
  • 試薬・キット
• 用途別
  • 研究
  • 臨床診断
• エンドユーザー別
  • 病院
  • 臨床診断検査室
  • 製薬産業
  • その他
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 ラジオイムノアッセイ（RIA）市場の企業と製品のプロファイル

• DIAsource
• Danaher Corporation
• Tecan Trading AG
• Merck KGaA
• MP BIOMEDICALS
• Svar Life Science
• Institute of Isotopes Co. Ltd.
• PerkinElmer Inc.

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Radioimmunoassay Market in Global (2021-2030)
• Table 3: Radioimmunoassay Market in Global by Product Type (2021-2030)
• Table 4: Radioimmunoassay Market in Global by Application (2021-2030)
• Table 5: Radioimmunoassay Market in Global by End-User (2021-2030)
• Table 6: Radioimmunoassay Market in Global by Geography (2021-2030)
• Table 7: Radioimmunoassay Market in North America (2021-2030)
• Table 8: Radioimmunoassay Market in the US (2021-2030)
• Table 9: Radioimmunoassay Market in Canada (2021-2030)
• Table 10: Radioimmunoassay Market in Mexico (2021-2030)
• Table 11: Radioimmunoassay Market in Europe (2021-2030)
• Table 12: Radioimmunoassay Market in France (2021-2030)
• Table 13: Radioimmunoassay Market in Germany (2021-2030)
• Table 14: Radioimmunoassay Market in the United Kingdom (2021-2030)
• Table 15: Radioimmunoassay Market in Italy (2021-2030)
• Table 16: Radioimmunoassay Market in Spain (2021-2030)
• Table 17: Radioimmunoassay Market in the Rest of Europe (2021-2030)
• Table 18: Radioimmunoassay Market in Asia-Pacific (2021-2030)
• Table 19: Radioimmunoassay Market in China (2021-2030)
• Table 20: Radioimmunoassay Market in Japan (2021-2030)
• Table 21: Radioimmunoassay Market in India (2021-2030)
• Table 22: Radioimmunoassay Market in Australia (2021-2030)
• Table 23: Radioimmunoassay Market in South Korea (2021-2030)
• Table 24: Radioimmunoassay Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Radioimmunoassay Market in the Rest of the World (2021-2030)
• Table 26: Radioimmunoassay Market in the Middle East (2021-2030)
• Table 27: Radioimmunoassay Market in Africa (2021-2030)
• Table 28: Radioimmunoassay Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Radioimmunoassay Market in Global (2021-2030)
• Figure 3: Radioimmunoassay Market in Global by Product Type (2021-2030)
• Figure 4: Radioimmunoassay Market in Global by Application (2021-2030)
• Figure 5: Radioimmunoassay Market in Global by End-User (2021-2030)
• Figure 6: Radioimmunoassay Market in Global by Geography (2021-2030)
• Figure 7: Radioimmunoassay Market in North America (2021-2030)
• Figure 8: Radioimmunoassay Market in the US (2021-2030)
• Figure 9: Radioimmunoassay Market in Canada (2021-2030)
• Figure 10: Radioimmunoassay Market in Mexico (2021-2030)
• Figure 11: Radioimmunoassay Market in Europe (2021-2030)
• Figure 12: Radioimmunoassay Market in France (2021-2030)
• Figure 13: Radioimmunoassay Market in Germany (2021-2030)
• Figure 14: Radioimmunoassay Market in the United Kingdom (2021-2030)
• Figure 15: Radioimmunoassay Market in Italy (2021-2030)
• Figure 16: Radioimmunoassay Market in Spain (2021-2030)
• Figure 17: Radioimmunoassay Market in the Rest of Europe (2021-2030)
• Figure 18: Radioimmunoassay Market in Asia-Pacific (2021-2030)
• Figure 19: Radioimmunoassay Market in China (2021-2030)
• Figure 20: Radioimmunoassay Market in Japan (2021-2030)
• Figure 21: Radioimmunoassay Market in India (2021-2030)
• Figure 22: Radioimmunoassay Market in Australia (2021-2030)
• Figure 23: Radioimmunoassay Market in South Korea (2021-2030)
• Figure 24: Radioimmunoassay Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Radioimmunoassay Market in the Rest of the World (2021-2030)
• Figure 26: Radioimmunoassay Market in the Middle East (2021-2030)
• Figure 27: Radioimmunoassay Market in Africa (2021-2030)
• Figure 28: Radioimmunoassay Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

The Radioimmunoassay (RIA) Market By Product Type (Analyzers And Reagents & Kits), Application (Research And Clinical Diagnostics), End-User (Hospitals, Clinical Diagnostic Laboratories, Pharmaceutical Industries, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing number of people with infectious diseases and increasing research and development activities

The global Radioimmunoassay (RIA) market was valued at USD 523.98 million in 2023, growing at a CAGR of 3.36% during the forecast period from 2024 to 2030 to reach USD 660.31 million by 2030. The demand for radioimmunoassay is primarily being boosted by the growing prevalence of cancer, infectious diseases, and others, rising incidences of epidemics and pandemics coupled with growing awareness of health. Furthermore, the radioimmunoassay market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the radioimmunoassay market during the forecast period from 2024-2030.

Radioimmunoassay (RIA) Market Dynamics:

The study conducted by the International Agency for Research on Cancer mentioned that worldwide, an estimated 19.3 million new cancer cases were reported in 2020.

According to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

The increasing burden of cancer necessitates its early and effective diagnosis which can be possible via the usage of radioimmunoassay. Radioimmunoassay is found to be crucial for detecting the early stages of cancer of the colon and pancreas among others.

Also, according to the World Health Organization (WHO) 2022, globally around 37.7 million people suffered from human immunodeficiency virus (HIV) in the year 2020. As per the 2023 data provided by WHO, globally around 10 million people suffered from tuberculosis in 2022. The estimates suggest that the prevalence of infectious diseases is on the rise and will increase the demand for radioimmunoassay for its effective diagnosis.

However, several limitations such as the use of radioactive substances, the need for advanced lab facilities, and others associated with the use of radioimmunoassay coupled with other diagnostic tools and methods may restrict the growth of the overall radioimmunoassay market.

Radioimmunoassay (RIA) Market Segment Analysis:

Radioimmunoassay Market by Product Type (Analyzers and Reagents & Kits), Application (Research and Clinical Diagnostics), End-User (Hospitals, Clinical Diagnostic Laboratories, Pharmaceutical Industries, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type of the radioimmunoassay market, the analyzers, category is expected to amass a significant revenue share in the year 2023.

This can be ascribed to the high incidence of infectious diseases, including hepatitis, and others along with rising incidences of epidemics and pandemics across the globe.

As per the data provided by the WHO 2022, globally around 241 million people suffered from malaria in 2020.

The WHO 2021 data mentioned that, worldwide around 1 million people acquire STDs every day. Also, as per the same source, it was estimated that there were around 129 million cases of chlamydia, 7.1 million cases of syphilis, 82 million cases of gonorrhea, and around 156 million cases of trichomoniasis recorded in the year 2020.

As per Centers for Disease Control and Prevention 2021 based on WHO estimates, in 2019 about 296 million people worldwide were living with hepatitis B, and 58 million people worldwide had hepatitis C.

Radioimmunoassay analyzers can be used to identify and detect the concentration of specific substances in a sample and can perform a variety of tests. The analyzers offer improved reliability, have intuitive interfaces and easy-to-use features.

Therefore, owing to the above-mentioned factors, the analyzers category is expected to register significant growth, thereby driving the growth of the overall radioimmunoassay market during the forecast period.

North America is expected to dominate the overall Radioimmunoassay (RIA) Market:

Among all the regions, North America is estimated to account for the largest share of the Radioimmunoassay market in the year 2023. This can be ascribed to the presence of a large patient pool associated with Sexually transmitted diseases (STSs), cancer, and others, a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

According to the Centers for Disease Control and Prevention 2022, it was estimated that around 1,189,700 people aged 13 and above had HIV in the US in 2019. As per the Centers for Disease Control and Prevention (CDC) (2022), around 1,752,735 new cancer cases were reported in 2019.

As per the American Thyroid Association 2019, around 20 million people in America have some form of thyroid disease, and an estimated 12 percent or more of American people will develop thyroid disease during their lifetime.

Moreover, as per the US Department of Health and Human Services (HHS) press release in the year 2021, the US government had invested USD 650 million in rapid diagnostic testing in the latest action to increase access to tests.

Thus, the above-mentioned factors are likely to propel the growth of the Radioimmunoassay market in the region during the forecast period from 2024-2030.

Radioimmunoassay (RIA) Market Key Players:

Some of the key market players operating in the Radioimmunoassay market include DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc., Danaher Corporation, and Others.

Key Takeaways from the Radioimmunoassay (RIA) Market Report Study

• Market size analysis for current Radioimmunoassay market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Radioimmunoassay market.
• Various opportunities available for the other competitors in the Radioimmunoassay market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Radioimmunoassay market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Radioimmunoassay market growth in the coming future?

Target Audience who can be benefited from this Radioimmunoassay (RIA) Market Report Study

• Radioimmunoassay product providers
• Research organizations and consulting companies
• Radioimmunoassay-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in radioimmunoassays
• Various End-users who want to know more about the radioimmunoassay market and the latest developments in the radioimmunoassay market.

Frequently Asked Questions for the Radioimmunoassay (RIA) Market:

1. What is radioimmunoassay?

Radioimmunoassay is for determining antibody levels by introducing an antigen labeled with a radioisotope and measuring the subsequent radioactivity of the antibody component.

2. What is the market for global radioimmunoassay?

The global Radioimmunoassay (RIA) market was valued at USD 523.98 million in 2023, growing at a CAGR of 3.36% during the forecast period from 2024 to 2030 to reach USD 660.31 million by 2030.

3. What are the drivers for the global radioimmunoassay market?

The demand for radioimmunoassay is primarily being boosted by the growing prevalence of cancer, infectious diseases, and others, rising incidences of epidemics and pandemics coupled with growing health awareness. Furthermore, the radioimmunoassay market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the radioimmunoassay market during the forecast period from 2024-2030.

4. Who are the key players operating in the global radioimmunoassay market?

Some of the key market players operating in the radioimmunoassay market include DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc., Danaher Corporation, and Others.

5. Which region has the highest share in the radioimmunoassay market?

North America is expected to dominate the overall radioimmunoassay market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the presence of a large patient pool associated with Sexually transmitted diseases (STSs), cancer, and others, a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1. Radioimmunoassay Market Report Introduction

2. Radioimmunoassay Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Radioimmunoassay Market Key Factors Analysis

• 4.1. Radioimmunoassay Market Drivers
  • 4.1.1. Increasing prevalence of infectious diseases such as tuberculosis, Hepatitis B, and others
  • 4.1.2. Increasing incidences of epidemics and pandemics
  • 4.1.3. Increasing awareness of health
• 4.2. Radioimmunoassay Market Restraints and Challenges
  • 4.2.1. Availability of alternative diagnostic tools and methods
  • 4.2.2. Limitations associated with radioimmunoassay
• 4.3. Radioimmunoassay Market Opportunities
  • 4.3.1. Growing need to improve the safety and accuracy of radioimmunoassay

5. Radioimmunoassay Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Radioimmunoassay Market Layout

• 6.1. By Product Type
  • 6.1.1. Analyzers
  • 6.1.2. Reagents & Kits
• 6.2. By Application
  • 6.2.1. Research
  • 6.2.2. Clinical Diagnostics
• 6.3. By End-User
  • 6.3.1. Hospitals
  • 6.3.2. Clinical Diagnostic Laboratories
  • 6.3.3. Pharmaceutical Industries
  • 6.3.4. Others
• 6.4. By Geography
  • 6.4.1. North America
    • 6.4.1.1. United States Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Radioimmunoassay Market Size in USD million (2021-2030)
  • 6.4.2. Europe
    • 6.4.2.1. France Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Radioimmunoassay Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific
    • 6.4.3.1. China Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3.3. India Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3.4. Australia Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of Asia-Pacific Radioimmunoassay Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW)
    • 6.4.4.1. Middle East Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.4.2. Africa Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.4.3. South America Radioimmunoassay Market Size in USD million (2021-2030)

7. Radioimmunoassay Market Company and Product Profiles

• 7.1. DIAsource
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Danaher Corporation
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Tecan Trading AG
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Merck KGaA
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. MP BIOMEDICALS
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Svar Life Science
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Institute of Isotopes Co. Ltd.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. PerkinElmer Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us